Episodes

On this Precision Medicine Podcast, author and CEO of the Toft Group (a ZRG company), Robin Toft, joins us to discuss her new book, We Can, and share her thoughts on the need for more women and greater diversity in the C-suite and the boardroom within the life science industry. Read the full summary here.

On this Precision Medicine Podcast, author and CEO of the Toft Group (a ZRG company), Robin Toft, joins us to discuss her new book, We Can, and share her thoughts on the need for more women and greater diversity in the C-suite and the boardroom within the life science industry. Read the full summary here.

Roy Smythe, M.D, explains why proteins are more useful than genes for understanding the human body and creating precision medicines to heal it. Dr. Smythe is CEO of SomaLogic, a leading-edge, biotechnology company headquartered in Boulder, Colorado. The company scans human proteins to gain insights into the past, current, and future health of patients, making it a promising new technology for precision medicine outcomes. Tune in here for the full summary and more :https://www.trapelohealth.com/...

Roy Smythe, M.D, explains why proteins are more useful than genes for understanding the human body and creating precision medicines to heal it. Dr. Smythe is CEO of SomaLogic, a leading-edge, biotechnology company headquartered in Boulder, Colorado. The company scans human proteins to gain insights into the past, current, and future health of patients, making it a promising new technology for precision medicine outcomes. Tune in here for the full summary and more :https://www.trapelohealth.com/...

Roy Smythe, M.D, explains why proteins are more useful than genes for understanding the human body and creating precision medicines to heal it. Dr. Smythe is CEO of SomaLogic, a leading-edge, biotechnology company headquartered in Boulder, Colorado. The company scans human proteins to gain insights into the past, current, and future health of patients, making it a promising new technology for precision medicine outcomes. Tune in here for the full summary and more :https://www.trapelohealth.com/...

In this Precision Medicine Podcast episode, we met with lung cancer patients Lisa Goldman and Tori Tomalia to discuss their organization, the ROS1ders, which they created to advocate and support those with ROS1-positive cancer—a group that represents just 2% of lung cancer patients. We were fascinated by how two women with no medical background could form a highly respected and resourceful group for those with this rare type of cancer. The women told us that when they and a mutual friend Janet ...

In this Precision Medicine Podcast episode, we met with lung cancer patients Lisa Goldman and Tori Tomalia to discuss their organization, the ROS1ders, which they created to advocate and support those with ROS1-positive cancer—a group that represents just 2% of lung cancer patients. We were fascinated by how two women with no medical background could form a highly respected and resourceful group for those with this rare type of cancer. The women told us that when they and a mutual friend Janet ...

In this Precision Medicine Podcast episode, we met with lung cancer patients Lisa Goldman and Tori Tomalia to discuss their organization, the ROS1ders, which they created to advocate and support those with ROS1-positive cancer—a group that represents just 2% of lung cancer patients. We were fascinated by how two women with no medical background could form a highly respected and resourceful group for those with this rare type of cancer. The women told us that when they and a mutual friend Janet ...

In our second podcast with Dr. John Quackenbush, Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health, we delved deeper into his approach to understanding cancer by studying entire gene networks rather than simple mutations. Read the full summary here, subscribe and learn more about our lead sponsor Trapelo Health.

In our second podcast with Dr. John Quackenbush, Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health, we delved deeper into his approach to understanding cancer by studying entire gene networks rather than simple mutations. Read the full summary here, subscribe and learn more about our lead sponsor Trapelo Health.

In our second podcast with Dr. John Quackenbush, Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health, we delved deeper into his approach to understanding cancer by studying entire gene networks rather than simple mutations. Read the full summary here, subscribe and learn more about our lead sponsor Trapelo Health.

In this episode of The Precision Medicine Podcast, we speak with Dr. Arturo Loaiza-Bonilla, Chief Medical Officer and Director of Research for the Cancer Treatment Centers of America in Philadelphia, about how precision medicine is changing the treatment of GI cancers. Learn about the personal experiences that inspired his medical career focus and the hidden talent that nearly stole him away.

In this episode of The Precision Medicine Podcast, we speak with Dr. Arturo Loaiza-Bonilla, Chief Medical Officer and Director of Research for the Cancer Treatment Centers of America in Philadelphia, about how precision medicine is changing the treatment of GI cancers. Learn about the personal experiences that inspired his medical career focus and the hidden talent that nearly stole him away.

In this episode of The Precision Medicine Podcast, we speak with Dr. Arturo Loaiza-Bonilla, Chief Medical Officer and Director of Research for the Cancer Treatment Centers of America in Philadelphia, about how precision medicine is changing the treatment of GI cancers. Learn about the personal experiences that inspired his medical career focus and the hidden talent that nearly stole him away.

In this episode 32 of the Precision Medicine Podcast sponsored by Trapelo, we talk extensively with Barbara Fortini, PhD, the Program Director for the Master of Science in Human Genetics and Genomic Data Analytics program at the Keck Graduate Institute about what students of biology and genetics need to know today versus what they needed to know a decade ago, and how she sees those skills being applied in a clinical setting. Read the full summary, download the transcript and tune in here. Learn ...

In this episode 32 of the Precision Medicine Podcast sponsored by Trapelo, we talk extensively with Barbara Fortini, PhD, the Program Director for the Master of Science in Human Genetics and Genomic Data Analytics program at the Keck Graduate Institute about what students of biology and genetics need to know today versus what they needed to know a decade ago, and how she sees those skills being applied in a clinical setting. Read the full summary, download the transcript and tune in here. Learn ...

In this episode 32 of the Precision Medicine Podcast sponsored by Trapelo, we talk extensively with Barbara Fortini, PhD, the Program Director for the Master of Science in Human Genetics and Genomic Data Analytics program at the Keck Graduate Institute about what students of biology and genetics need to know today versus what they needed to know a decade ago, and how she sees those skills being applied in a clinical setting. Read the full summary, download the transcript and tune in here. Learn ...

Dr. Adam Brufsky, Medical Director for the Women’s Cancer Program at the UPMC Hillman Cancer Center, shares the newest findings from the San Antonio Breast Cancer Symposium (SABCS) and discusses the important role of precision medicine in breast cancer care. Tune in and #Subscribe here https://bit.ly/2sT9y8r #PrecisionMedicinePodcast #SABC19

Dr. Adam Brufsky, Medical Director for the Women’s Cancer Program at the UPMC Hillman Cancer Center, shares the newest findings from the San Antonio Breast Cancer Symposium (SABCS) and discusses the important role of precision medicine in breast cancer care. Tune in and #Subscribe here https://bit.ly/2sT9y8r #PrecisionMedicinePodcast #SABC19

Dr. Adam Brufsky, Medical Director for the Women’s Cancer Program at the UPMC Hillman Cancer Center, shares the newest findings from the San Antonio Breast Cancer Symposium (SABCS) and discusses the important role of precision medicine in breast cancer care. Tune in and #Subscribe here https://bit.ly/2sT9y8r #PrecisionMedicinePodcast #SABC19

In this first episode of season two of the Precision Medicine Podcast, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project. Read our full summary and tune in to the episode here.

In this first episode of season two of the Precision Medicine Podcast, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project. Read our full summary and tune in to the episode here.

In this first episode of season two of the Precision Medicine Podcast, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project. Read our full summary and tune in to the episode here.

In this episode, we speak with Dr. Selin Kurnaz, CEO and cofounder of Massive Bio, who led a panel at the Precision Medicine Leadership Summit in Philadelphia. The panel discussion, Precision Medicine Clinical Trials and Novel Designs: Levering Data, ‘Omics’, AI and Policy focused on the importance of increasing patient accessibility to clinical trials, an issue that drove Dr. Kurnaz to cofound her company. Read more in our full summary and tune in to the episode here.